IOVA icon

Iovance Biotherapeutics
IOVA

Overview Fund Activity

226 hedge funds and large institutions have $970M invested in Iovance Biotherapeutics in 2023 Q3 according to their latest regulatory filings, with 41 funds opening new positions, 106 increasing their positions, 52 reducing their positions, and 31 closing their positions.

Holders
226
Holders Change
+8
Holders Change %
+3.67%
% of All Funds
3.6%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
41
Increased
106
Reduced
52
Closed
31
Calls
$33.7M
Puts
$16.2M
Net Calls
+$17.4M
Net Calls Change
+$12.4M

Top Buyers

1
MFM
1
MHR Fund Management
New York
$91M
2
Pictet Asset Management
2
Pictet Asset Management
Switzerland
$31.5M
3
Millennium Management
3
Millennium Management
New York
$35.6M
4
State Street
4
State Street
Massachusetts
$76.1M
5
Balyasny Asset Management
5
Balyasny Asset Management
Illinois
$20.4M

Top Sellers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$6.43M
2
Sumitomo Mitsui Trust Group
2
Sumitomo Mitsui Trust Group
Japan
$0
3
NAMA
3
Nikko Asset Management Americas
New York
$0
4
Deutsche Bank
4
Deutsche Bank
Germany
$2.29M
5
PA
5
Perceptive Advisors
New York
$54.4M
Name Market Value Shares Shares
Change 		Shares
Change %
Vanguard Group
1
Vanguard Group
Pennsylvania
$101M 22,143,470 +1,748,082 +9%
MFM
2
MHR Fund Management
New York
$91M 19,997,103 +8,000,000 +67%
BlackRock
3
BlackRock
New York
$83.6M 18,376,429 +1,374,638 +8%
State Street
4
State Street
Massachusetts
$76.1M 16,732,269 +3,166,471 +23%
PA
5
Perceptive Advisors
New York
$54.4M 11,962,938 -2,073,472 -15%
Millennium Management
6
Millennium Management
New York
$35.6M 7,820,074 +4,239,406 +118%
Pictet Asset Management
7
Pictet Asset Management
Switzerland
$31.5M 6,913,684 +6,913,684 New
ACA
8
Avoro Capital Advisors
New York
$30.5M 6,700,000 – –
Artisan Partners
9
Artisan Partners
Wisconsin
$22.9M 5,036,479 +609,738 +14%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$21.6M 4,749,411 +611,049 +15%
O
11
OrbiMed
New York
$21.4M 4,707,458 – –
Balyasny Asset Management
12
Balyasny Asset Management
Illinois
$20.4M 4,476,836 +2,937,029 +191%
Dimensional Fund Advisors
13
Dimensional Fund Advisors
Texas
$18.1M 3,978,385 +1,881,382 +90%
Goldman Sachs
14
Goldman Sachs
New York
$17.1M 3,763,638 +228,371 +6%
BC
15
Boxer Capital
California
$16.9M 3,705,133 – –
T. Rowe Price Associates
16
T. Rowe Price Associates
Maryland
$16.4M 3,597,120 -66,253 -2%
MB
17
MPM BioImpact
Massachusetts
$15M 3,287,397 +337,279 +11%
CS
18
Credit Suisse
Switzerland
$12.9M 2,843,469 +49,345 +2%
CS
19
Candriam SCA
Luxembourg
$12.5M 2,747,853 +1,020,037 +59%
JPMorgan Chase & Co
20
JPMorgan Chase & Co
New York
$12.5M 2,746,356 +111,069 +4%
Principal Financial Group
21
Principal Financial Group
Iowa
$12M 2,643,155 +772,905 +41%
Morgan Stanley
22
Morgan Stanley
New York
$11.3M 2,482,125 -1,015,483 -29%
LFCM
23
Long Focus Capital Management
Puerto Rico
$11.2M 2,470,521 +593,707 +32%
6CM
24
683 Capital Management
New York
$9.33M 2,050,000 +650,000 +46%
Northern Trust
25
Northern Trust
Illinois
$9.07M 1,993,179 +180,930 +10%
1
2 3 4 5